Further research is needed to elucidate the specific mechanisms by which cholesterol affects BSEP function and to determine whether this approach may be a viable therapeutic option for patients with cholestatic liver diseases (Engelmann et al., 2015). The gene discussed is ABCB11; the disease is Cholestatic liver disease.